Dr. Igor Splawski Appointed Chief Scientific Officer of Yarrow Biotechnology | citybiz

Dr. Igor Splawski Appointed Chief Scientific Officer of Yarrow Biotechnology |  citybiz

Dr. Igor Splawski NEW YORK–(BUSINESS WIRE)–Yarrow Biotechnology, Inc.A RTW Investments, L.P Incubated company developing nucleic acid therapies and other modalities for serious genetically defined diseases, including those of the central nervous system, today announced the appointment of Dr. Igor Splawski as Scientific Director. Dr. Splawski was previously Chief Scientific Officer and a member of the … Read more